<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:wfw="http://wellformedweb.org/CommentAPI/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" > <channel> <title>JettSet1 Enterprises Archives — Black Cannabis Magazine</title> <atom:link href="https://blackcannabismagazine.com/tag/jettset1-enterprises/feed/" rel="self" type="application/rss+xml" /> <link>https://blackcannabismagazine.com/tag/jettset1-enterprises/</link> <description>We educate, inform, empower + provide entertainment for our TRIBE. Highlighting people of color in the cannabis industry.</description> <lastBuildDate>Wed, 28 Jun 2023 15:18:27 +0000</lastBuildDate> <language>en-US</language> <sy:updatePeriod> hourly </sy:updatePeriod> <sy:updateFrequency> 1 </sy:updateFrequency> <generator>https://wordpress.org/?v=6.7.2</generator> <image> <url>https://i0.wp.com/blackcannabismagazine.com/wp-content/uploads/2023/04/cropped-9A031074-6155-49D0-91F9-3CD39BD7AB82.png?fit=32%2C32&ssl=1</url> <title>JettSet1 Enterprises Archives — Black Cannabis Magazine</title> <link>https://blackcannabismagazine.com/tag/jettset1-enterprises/</link> <width>32</width> <height>32</height> </image> <site xmlns="com-wordpress:feed-additions:1">169930730</site> <item> <title>Cannabinoid Treatment for Angelman Syndrome: The Promising Alliance of JettSet1 and Biom Therapeutics</title> <link>https://blackcannabismagazine.com/cannabinoid-treatment-for-angelman-syndrome-the-promising-alliance-of-jettset1-and-biom-therapeutics/</link> <comments>https://blackcannabismagazine.com/cannabinoid-treatment-for-angelman-syndrome-the-promising-alliance-of-jettset1-and-biom-therapeutics/?noamp=mobile#respond</comments> <dc:creator><![CDATA[Hazey Taughtme]]></dc:creator> <pubDate>Wed, 28 Jun 2023 15:18:27 +0000</pubDate> <category><![CDATA[Health]]></category> <category><![CDATA[Angelman Syndrome]]></category> <category><![CDATA[Autism Spectrum Disorder]]></category> <category><![CDATA[Biom Therapeutics]]></category> <category><![CDATA[Bobban Subhadra]]></category> <category><![CDATA[Breakthrough Science.]]></category> <category><![CDATA[Cannabidiol-based drugs]]></category> <category><![CDATA[Cbd]]></category> <category><![CDATA[FDA Approved]]></category> <category><![CDATA[Flo Rida]]></category> <category><![CDATA[George Tabi]]></category> <category><![CDATA[JettSet1 Enterprises]]></category> <category><![CDATA[Orphan Drug]]></category> <category><![CDATA[Tramar Dillard]]></category> <guid isPermaLink="false">https://blackcannabismagazine.com/?p=197778</guid> <description><![CDATA[<p>Cannabinoid Treatment for Angelman Syndrome: A Groundbreaking Alliance Paves the Way Cannabinoid treatment for Angelman Syndrome is witnessing a revolutionary advancement. The novel alliance between JettSet1 Enterprises and Biom Therapeutics marks a significant milestone in the journey towards an effective therapy. Decoding Angelman Syndrome Angelman Syndrome is a complex genetic disorder with a primary impact […]</p> <p>The post <a href="https://blackcannabismagazine.com/cannabinoid-treatment-for-angelman-syndrome-the-promising-alliance-of-jettset1-and-biom-therapeutics/">Cannabinoid Treatment for Angelman Syndrome: The Promising Alliance of JettSet1 and Biom Therapeutics</a> appeared first on <a href="https://blackcannabismagazine.com">Black Cannabis Magazine</a>.</p> ]]></description> <content:encoded><![CDATA[<h3><strong>Cannabinoid Treatment for Angelman Syndrome: A Groundbreaking Alliance Paves the Way</strong></h3> <p>Cannabinoid treatment for <a href="https://medlineplus.gov/genetics/condition/angelman-syndrome/">Angelman Syndrome</a> is witnessing a revolutionary advancement. The novel alliance between JettSet1 Enterprises and Biom Therapeutics marks a significant milestone in the journey towards an effective therapy.</p> <h3><strong>Decoding Angelman Syndrome</strong></h3> <p>Angelman Syndrome is a complex genetic disorder with a primary impact on the nervous system. Its characteristic features include delayed development, intellectual disability, severe speech impairment, and movement and balance difficulties. Most individuals with this condition also experience recurrent seizures and have a smaller head size, a condition known as microcephaly. The signs of this disorder start becoming noticeable between the age of 6 to 12 months.</p> <p>People with Angelman Syndrome frequently exhibit a cheerful demeanor, characterized by constant smiling, laughter, and hand-flapping movements. Common accompanying conditions include hyperactivity and a short attention span. Sleep disturbances are common but tend to improve with age, even as the excitability decreases. However, intellectual disability, severe speech impairment, and seizures continue throughout the lifetime.</p> <h3><strong>Biom Therapeutics: Spearheading Cannabidiol-based Drug Development</strong></h3> <p>Biom Therapeutics, a preclinical-stage company, has gained recognition for its intensive research and development of Cannabidiol (CBD)-based drugs. Their concentrated efforts are targeted towards treating neurodevelopmental conditions, particularly Angelman Syndrome. The patent-pending, water-soluble CBD formulations developed by the company present a significant advancement in the field.</p> <h3><strong>BIO017: A Ray of Hope for Angelman Syndrome</strong></h3> <p>Biom Therapeutics’ lead drug candidate, BIO017, was granted the first and only orphan drug approval status by the FDA in March 2021 for treating Angelman Syndrome. This coveted status facilitates the development of therapies for severe and rare diseases, offering benefits such as seven years of market exclusivity and exemption from FDA application fees.</p> <h3><strong>JettSet1 Enterprises: A Personal Mission and Vision</strong></h3> <p>Flo Rida, a co-founder of JettSet1 and a globally renowned artist, brings a personal commitment to this alliance. As a parent of a child diagnosed with autism, his mission extends beyond business objectives. He aspires to bring attention to these ground-breaking scientific advancements, promoting awareness about neurodevelopmental disorders and potential treatments across the globe.</p> <p>The post <a href="https://blackcannabismagazine.com/cannabinoid-treatment-for-angelman-syndrome-the-promising-alliance-of-jettset1-and-biom-therapeutics/">Cannabinoid Treatment for Angelman Syndrome: The Promising Alliance of JettSet1 and Biom Therapeutics</a> appeared first on <a href="https://blackcannabismagazine.com">Black Cannabis Magazine</a>.</p> ]]></content:encoded> <wfw:commentRss>https://blackcannabismagazine.com/cannabinoid-treatment-for-angelman-syndrome-the-promising-alliance-of-jettset1-and-biom-therapeutics/feed/</wfw:commentRss> <slash:comments>0</slash:comments> <post-id xmlns="com-wordpress:feed-additions:1">197778</post-id> </item> </channel> </rss> <!-- Performance optimized by W3 Total Cache. Learn more: https://www.boldgrid.com/w3-total-cache/ Page Caching using Disk: Enhanced{w3tc_pagecache_reject_reason} Served from: blackcannabismagazine.com @ 2025-02-25 10:49:18 by W3 Total Cache -->